Eye tracking metrics to screen and assess cognitive impairment in patients with neurological disorders.
Ling TaoQuan WangDing LiuJing WangZiqing ZhuLi FengPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
Eye tracking tasks (especially saccadic tasks) are often used as an adjunct to traditional scales for cognitive assessment. Eye tracking data confirmed that executive dysfunction is common in PD and ALS, whereas AD and MS are characterized by attention deficits. Research in evaluating cognitive function in epilepsy using eye tracking is still in its early stages, but this approach has shown advantages as a sensitive quantitative method with high temporal and spatial resolution. Eye tracking technology can facilitate the assessment of cognitive impairment with higher temporal resolution and finer granularity than traditional cognitive assessment. Oculomotor data collected during cognitive tasks can provide insight into biological processes. Eye tracking provides a nonverbal and less cognitively demanding method of measuring disease progression in cognitively impaired patients.
Keyphrases
- working memory
- cognitive impairment
- end stage renal disease
- multiple sclerosis
- traumatic brain injury
- chronic kidney disease
- newly diagnosed
- ejection fraction
- electronic health record
- cognitive decline
- oxidative stress
- ms ms
- high resolution
- high throughput
- patient reported outcomes
- peritoneal dialysis
- patient reported